Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population
about
Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factorsBarriers to hepatitis C antiviral therapy in HIV/HCV co-infected patients in the United States: a reviewInfectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis.Patient and provider characteristics associated with the decision of HIV coinfected patients to start hepatitis C treatment.Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.The hepatitis C cascade of care: identifying priorities to improve clinical outcomesThe hepatitis C cascade of care among HIV infected patients: a call to address ongoing barriers to care.Hepatitis B and C infection and liver disease trends among human immunodeficiency virus-infected individuals.Impact of hepatitis coinfection on healthcare utilization among persons living with HIV.Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional studyAn interrupted time series evaluation of a hepatitis C intervention for persons with HIV.Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment.U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model.Substance abuse treatment in persons with HIV/AIDS: challenges in managing triple diagnosis.Rates and predictors of response to anti-viral treatment for hepatitis C virus in HIV/HCV co-infection in a nationwide study of 619 patients.
P2860
Q26853671-F7DF1FDE-92D6-4A3A-9E9D-09E29E404AC6Q27010548-10EF47D4-1A6C-4112-A5DC-475696C5B5DAQ30395708-8D85F13F-68AF-49AE-83C2-656C37637D9AQ30405780-7E51781E-D617-4B33-9989-5DBE86B62C72Q30751889-8EAF608A-0899-4FCB-B79D-A5827C49F867Q33632459-0125320E-4D15-49E1-94D2-8379212DE0B4Q33921543-711B0F5B-629D-4198-9929-2E98F16A4364Q34831090-30A3AD52-5F7A-4D21-89DB-6346B9E856C1Q35106985-BF5923A6-0B2D-4D98-8C1B-6C1C80995A78Q35154639-AABEC367-0F5B-4C96-8026-1906CE8DD45BQ35177951-EED96F49-88BB-4C94-9338-06FDC2322AE6Q35184927-EDF5FA22-AF89-4854-9518-E0703720F9EDQ36501102-AAB022B6-4E01-4F22-8C0F-E63AFCFAAAFFQ36750449-D58F7EBC-C887-4EBE-B5E6-AC29B7AFBC4CQ37722613-137BD9C7-9C14-4AFA-9153-DC14752CE100Q42262341-0D82F519-12A8-4C5A-B898-7AD0C7D735E0
P2860
Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population
@ast
Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population
@en
type
label
Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population
@ast
Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population
@en
prefLabel
Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population
@ast
Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population
@en
P2093
P2860
P356
P1476
Hepatitis C virus is infrequently evaluated and treated in an urban HIV clinic population
@en
P2093
Chia C Wang
Elizabeth Krantz
John D Scott
Linda Drolette
Mari Kitahata
P2860
P304
P356
10.1089/APC.2009.0099
P577
2009-11-01T00:00:00Z